December ETH Price Prediction · Posting Challenge 📈
With rate-cut expectations heating up in December, ETH sentiment turns bullish again.
We’re opening a prediction challenge — Spot the trend · Call the market · Win rewards 💰
Reward 🎁:
From all correct predictions, 5 winners will be randomly selected — 10 USDT each
Deadline 📅: December 11, 12:00 (UTC+8)
How to join ✍️:
Post your ETH price prediction on Gate Square, clearly stating a price range
(e.g. $3,200–$3,400, range must be < $200) and include the hashtag #ETHDecPrediction
Post Examples 👇
Example ①: #ETHDecPrediction Range: $3,150–
Novo Nordisk: 7.2mg semaglutide phase 3 clinical trial met the primary endpoint with a weight loss of 20.7% at 72 weeks.
On January 18, Jins data reported that on January 17 local time, Novo Nordisk announced the main results of the 3b phase clinical trial STEP UP. In the STEP UP obesity trial, subcutaneous injection of 7.2mg semaglutide once a week resulted in a weight loss of 20.7% at 72 weeks, and a weight loss of 18.7% regardless of treatment compliance. The trial met its primary endpoint, with 7.2mg semaglutide showing statistically significant and superior weight loss compared to placebo at 72 weeks.